Global Active Pharmaceutical Ingredient Market Report 2019, Competitive Landscape, Trends and Opportunities

1 Active Pharmaceutical Ingredient Market Overview

1.1 Product Overview and Scope of Active Pharmaceutical Ingredient

1.2 Active Pharmaceutical Ingredient Segment by Type

1.2.1 Global Active Pharmaceutical Ingredient Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Biotech API

1.2.3 The Market Profile of Synthetic API

1.2.4 The Market Profile of Others

1.3 Global Active Pharmaceutical Ingredient Segment by Application

1.3.1 Active Pharmaceutical Ingredient Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Anti-diabetic Drugs

1.3.3 The Market Profile of Oncology Drugs

1.3.4 The Market Profile of Non-steroidal Anti-inflammatory Drugs (NSAIDs)

1.4 Global Active Pharmaceutical Ingredient Market by Region (2014-2026)

1.4.1 Global Active Pharmaceutical Ingredient Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.3 Europe Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.3.1 Germany Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.3.2 UK Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.3.3 France Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.3.4 Italy Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.3.5 Spain Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.3.6 Russia Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.3.7 Poland Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.4 China Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.5 Japan Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.6 India Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.8 Central and South America Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Active Pharmaceutical Ingredient Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Active Pharmaceutical Ingredient (2014-2026)

1.5.1 Global Active Pharmaceutical Ingredient Revenue Status and Outlook (2014-2026)

1.5.2 Global Active Pharmaceutical Ingredient Production Status and Outlook (2014-2026)

2 Global Active Pharmaceutical Ingredient Market Landscape by Player

2.1 Global Active Pharmaceutical Ingredient Production and Share by Player (2014-2019)

2.2 Global Active Pharmaceutical Ingredient Revenue and Market Share by Player (2014-2019)

2.3 Global Active Pharmaceutical Ingredient Average Price by Player (2014-2019)

2.4 Active Pharmaceutical Ingredient Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Active Pharmaceutical Ingredient Market Competitive Situation and Trends

2.5.1 Active Pharmaceutical Ingredient Market Concentration Rate

2.5.2 Active Pharmaceutical Ingredient Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Novartis

3.1.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.1.3 Novartis Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.1.4 Novartis Business Overview

3.2 Bachem

3.2.1 Bachem Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.2.3 Bachem Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.2.4 Bachem Business Overview

3.3 Haerbin Pharmaceutical Group

3.3.1 Haerbin Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.3.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.3.4 Haerbin Pharmaceutical Group Business Overview

3.4 Johnson Matthey

3.4.1 Johnson Matthey Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.4.3 Johnson Matthey Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.4.4 Johnson Matthey Business Overview

3.5 Pfizer

3.5.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.5.3 Pfizer Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.5.4 Pfizer Business Overview

3.6 Hisun Pharmacy

3.6.1 Hisun Pharmacy Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.6.3 Hisun Pharmacy Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.6.4 Hisun Pharmacy Business Overview

3.7 Jiangsu Hengrui Medicine

3.7.1 Jiangsu Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.7.3 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.7.4 Jiangsu Hengrui Medicine Business Overview

3.8 Aurobindo pharma

3.8.1 Aurobindo pharma Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.8.3 Aurobindo pharma Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.8.4 Aurobindo pharma Business Overview

3.9 North China Pharmaceutical Group

3.9.1 North China Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.9.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.9.4 North China Pharmaceutical Group Business Overview

3.10 Biocon

3.10.1 Biocon Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.10.3 Biocon Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.10.4 Biocon Business Overview

3.11 Mylan

3.11.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.11.3 Mylan Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.11.4 Mylan Business Overview

3.12 North East Pharmaceutical

3.12.1 North East Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.12.3 North East Pharmaceutical Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.12.4 North East Pharmaceutical Business Overview

3.13 Cipla

3.13.1 Cipla Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.13.3 Cipla Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.13.4 Cipla Business Overview

3.14 Lonza group

3.14.1 Lonza group Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.14.3 Lonza group Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.14.4 Lonza group Business Overview

3.15 Huahai Pharmaceutical

3.15.1 Huahai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.15.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.15.4 Huahai Pharmaceutical Business Overview

3.16 Cambrex

3.16.1 Cambrex Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.16.3 Cambrex Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.16.4 Cambrex Business Overview

3.17 Albemarle

3.17.1 Albemarle Basic Information, Manufacturing Base, Sales Area and Competitors

3.17.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.17.3 Albemarle Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.17.4 Albemarle Business Overview

3.18 Teva

3.18.1 Teva Basic Information, Manufacturing Base, Sales Area and Competitors

3.18.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.18.3 Teva Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.18.4 Teva Business Overview

3.19 BASF

3.19.1 BASF Basic Information, Manufacturing Base, Sales Area and Competitors

3.19.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.19.3 BASF Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.19.4 BASF Business Overview

3.20 Roche

3.20.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors

3.20.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.20.3 Roche Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.20.4 Roche Business Overview

3.21 Bayer

3.21.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors

3.21.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.21.3 Bayer Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.21.4 Bayer Business Overview

3.22 Dr. Reddy's Laboratories

3.22.1 Dr. Reddy's Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors

3.22.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.22.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.22.4 Dr. Reddy's Laboratories Business Overview

3.23 Shandong Xinhua Pharmaceutical

3.23.1 Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.23.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.23.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.23.4 Shandong Xinhua Pharmaceutical Business Overview

3.24 Shandong Lukang Pharmaceutical

3.24.1 Shandong Lukang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors

3.24.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.24.3 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.24.4 Shandong Lukang Pharmaceutical Business Overview

3.25 Lupin

3.25.1 Lupin Basic Information, Manufacturing Base, Sales Area and Competitors

3.25.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.25.3 Lupin Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.25.4 Lupin Business Overview

3.26 Johnson & Johnson

3.26.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors

3.26.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.26.3 Johnson & Johnson Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.26.4 Johnson & Johnson Business Overview

3.27 Sun Pharmaceutical Industries

3.27.1 Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Competitors

3.27.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.27.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.27.4 Sun Pharmaceutical Industries Business Overview

3.28 Tian Yao

3.28.1 Tian Yao Basic Information, Manufacturing Base, Sales Area and Competitors

3.28.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.28.3 Tian Yao Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.28.4 Tian Yao Business Overview

3.29 Boehringer Ingelheim GmbH

3.29.1 Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Competitors

3.29.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.29.3 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.29.4 Boehringer Ingelheim GmbH Business Overview

3.30 Zhejiang Medicine

3.30.1 Zhejiang Medicine Basic Information, Manufacturing Base, Sales Area and Competitors

3.30.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.30.3 Zhejiang Medicine Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.30.4 Zhejiang Medicine Business Overview

3.31 DSM

3.31.1 DSM Basic Information, Manufacturing Base, Sales Area and Competitors

3.31.2 Active Pharmaceutical Ingredient Product Profiles, Application and Specification

3.31.3 DSM Active Pharmaceutical Ingredient Market Performance (2014-2019)

3.31.4 DSM Business Overview

4 Global Active Pharmaceutical Ingredient Production, Revenue (Value), Price Trend by Type

4.1 Global Active Pharmaceutical Ingredient Production and Market Share by Type (2014-2019)

4.2 Global Active Pharmaceutical Ingredient Revenue and Market Share by Type (2014-2019)

4.3 Global Active Pharmaceutical Ingredient Price by Type (2014-2019)

4.4 Global Active Pharmaceutical Ingredient Production Growth Rate by Type (2014-2019)

4.4.1 Global Active Pharmaceutical Ingredient Production Growth Rate of Biotech API (2014-2019)

4.4.2 Global Active Pharmaceutical Ingredient Production Growth Rate of Synthetic API (2014-2019)

4.4.3 Global Active Pharmaceutical Ingredient Production Growth Rate of Others (2014-2019)

5 Global Active Pharmaceutical Ingredient Market Analysis by Application

5.1 Global Active Pharmaceutical Ingredient Consumption and Market Share by Application (2014-2019)

5.2 Global Active Pharmaceutical Ingredient Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Active Pharmaceutical Ingredient Consumption Growth Rate of Anti-diabetic Drugs (2014-2019)

5.2.2 Global Active Pharmaceutical Ingredient Consumption Growth Rate of Oncology Drugs (2014-2019)

5.2.3 Global Active Pharmaceutical Ingredient Consumption Growth Rate of Non-steroidal Anti-inflammatory Drugs (NSAIDs) (2014-2019)

6 Global Active Pharmaceutical Ingredient Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Active Pharmaceutical Ingredient Consumption by Region (2014-2019)

6.2 United States Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

6.3 Europe Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

6.4 China Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

6.5 Japan Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

6.6 India Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

7 Global Active Pharmaceutical Ingredient Production, Revenue (Value) by Region (2014-2019)

7.1 Global Active Pharmaceutical Ingredient Production and Market Share by Region (2014-2019)

7.2 Global Active Pharmaceutical Ingredient Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

8 Active Pharmaceutical Ingredient Manufacturing Analysis

8.1 Active Pharmaceutical Ingredient Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Active Pharmaceutical Ingredient Industrial Chain Analysis

9.2 Raw Materials Sources of Active Pharmaceutical Ingredient Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Active Pharmaceutical Ingredient

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter’s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Active Pharmaceutical Ingredient Market Forecast (2019-2026)

11.1 Global Active Pharmaceutical Ingredient Production, Revenue Forecast (2019-2026)

11.1.1 Global Active Pharmaceutical Ingredient Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Active Pharmaceutical Ingredient Price and Trend Forecast (2019-2026)

11.2 Global Active Pharmaceutical Ingredient Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Active Pharmaceutical Ingredient Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Active Pharmaceutical Ingredient Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Active Pharmaceutical Ingredient Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Active Pharmaceutical Ingredient Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Active Pharmaceutical Ingredient Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Active Pharmaceutical Ingredient Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Active Pharmaceutical Ingredient Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Active Pharmaceutical Ingredient Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Active Pharmaceutical Ingredient Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Active Pharmaceutical Ingredient Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source

List of Tables and Figures

Figure Active Pharmaceutical Ingredient Product Picture

Table Global Active Pharmaceutical Ingredient Production and CAGR (%) Comparison by Type

Table Profile of Biotech API

Table Profile of Synthetic API

Table Profile of Others

Table Active Pharmaceutical Ingredient Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Anti-diabetic Drugs

Table Profile of Oncology Drugs

Table Profile of Non-steroidal Anti-inflammatory Drugs (NSAIDs)

Figure Global Active Pharmaceutical Ingredient Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Europe Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Germany Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure UK Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure France Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Italy Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Spain Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Russia Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Poland Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure China Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Japan Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure India Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Malaysia Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Singapore Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Philippines Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Indonesia Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Thailand Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Vietnam Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Central and South America Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Brazil Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Mexico Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Colombia Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Turkey Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Egypt Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure South Africa Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Nigeria Active Pharmaceutical Ingredient Revenue and Growth Rate (2014-2026)

Figure Global Active Pharmaceutical Ingredient Production Status and Outlook (2014-2026)

Table Global Active Pharmaceutical Ingredient Production by Player (2014-2019)

Table Global Active Pharmaceutical Ingredient Production Share by Player (2014-2019)

Figure Global Active Pharmaceutical Ingredient Production Share by Player in 2018

Table Active Pharmaceutical Ingredient Revenue by Player (2014-2019)

Table Active Pharmaceutical Ingredient Revenue Market Share by Player (2014-2019)

Table Active Pharmaceutical Ingredient Price by Player (2014-2019)

Table Active Pharmaceutical Ingredient Manufacturing Base Distribution and Sales Area by Player

Table Active Pharmaceutical Ingredient Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table Novartis Profile

Table Novartis Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Bachem Profile

Table Bachem Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Haerbin Pharmaceutical Group Profile

Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Johnson Matthey Profile

Table Johnson Matthey Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Pfizer Profile

Table Pfizer Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Hisun Pharmacy Profile

Table Hisun Pharmacy Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Jiangsu Hengrui Medicine Profile

Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Aurobindo pharma Profile

Table Aurobindo pharma Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table North China Pharmaceutical Group Profile

Table North China Pharmaceutical Group Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Biocon Profile

Table Biocon Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Mylan Profile

Table Mylan Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table North East Pharmaceutical Profile

Table North East Pharmaceutical Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Cipla Profile

Table Cipla Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Lonza group Profile

Table Lonza group Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Huahai Pharmaceutical Profile

Table Huahai Pharmaceutical Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Cambrex Profile

Table Cambrex Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Albemarle Profile

Table Albemarle Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Teva Profile

Table Teva Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table BASF Profile

Table BASF Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Roche Profile

Table Roche Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Bayer Profile

Table Bayer Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Dr. Reddy's Laboratories Profile

Table Dr. Reddy's Laboratories Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Shandong Xinhua Pharmaceutical Profile

Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Shandong Lukang Pharmaceutical Profile

Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Lupin Profile

Table Lupin Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Johnson & Johnson Profile

Table Johnson & Johnson Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Sun Pharmaceutical Industries Profile

Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Tian Yao Profile

Table Tian Yao Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Boehringer Ingelheim GmbH Profile

Table Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Zhejiang Medicine Profile

Table Zhejiang Medicine Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table DSM Profile

Table DSM Active Pharmaceutical Ingredient Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Active Pharmaceutical Ingredient Production by Type (2014-2019)

Table Global Active Pharmaceutical Ingredient Production Market Share by Type (2014-2019)

Figure Global Active Pharmaceutical Ingredient Production Market Share by Type in 2018

Table Global Active Pharmaceutical Ingredient Revenue by Type (2014-2019)

Table Global Active Pharmaceutical Ingredient Revenue Market Share by Type (2014-2019)

Figure Global Active Pharmaceutical Ingredient Revenue Market Share by Type in 2018

Table Active Pharmaceutical Ingredient Price by Type (2014-2019)

Figure Global Active Pharmaceutical Ingredient Production Growth Rate of Biotech API (2014-2019)

Figure Global Active Pharmaceutical Ingredient Production Growth Rate of Synthetic API (2014-2019)

Figure Global Active Pharmaceutical Ingredient Production Growth Rate of Others (2014-2019)

Table Global Active Pharmaceutical Ingredient Consumption by Application (2014-2019)

Table Global Active Pharmaceutical Ingredient Consumption Market Share by Application (2014-2019)

Table Global Active Pharmaceutical Ingredient Consumption of Anti-diabetic Drugs (2014-2019)

Table Global Active Pharmaceutical Ingredient Consumption of Oncology Drugs (2014-2019)

Table Global Active Pharmaceutical Ingredient Consumption of Non-steroidal Anti-inflammatory Drugs (NSAIDs) (2014-2019)

Table Global Active Pharmaceutical Ingredient Consumption by Region (2014-2019)

Table Global Active Pharmaceutical Ingredient Consumption Market Share by Region (2014-2019)

Table United States Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

Table Europe Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

Table China Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

Table Japan Active Pharmaceutical Ingredient Production, Consumption, Export, Import (2014-2019)

Table India Active Pharmaceutical Ingredient Production,